Prefrontal Reactivity to Social Signals of Threat as a Predictor of Treatment Response in Anxious Youth

Neuropsychopharmacology

Volumn 41, Issue 8, 2016, Pages 1983-1990

  Kujawa, Autumn ^a   Swain, James E ^b   Hanna, Gregory L ^b   Koschmann, Elizabeth ^b   Simpson, David ^a   Connolly, Sucheta ^a   Fitzgerald, Kate D ^b   Monk, Christopher S ^b,c   Phan, K Luan ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; BRAIN FUNCTION; CHILD; CLINICAL ARTICLE; COGNITIVE BEHAVIORAL THERAPY; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENERALIZED ANXIETY DISORDER; HUMAN; INFERIOR FRONTAL GYRUS; MALE; POSTCENTRAL GYRUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEPARATION ANXIETY; SOCIAL PHOBIA; SUPERIOR FRONTAL GYRUS; THREAT; TREATMENT RESPONSE; VENTROLATERAL PREFRONTAL CORTEX; ANGER; BRAIN; BRAIN MAPPING; COGNITIVE THERAPY; FACIAL EXPRESSION; FACIAL RECOGNITION; FEAR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCEPTION; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ANGER; ANXIETY, SEPARATION; BRAIN; BRAIN MAPPING; CHILD; COGNITIVE THERAPY; FACIAL EXPRESSION; FACIAL RECOGNITION; FEAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHOBIA, SOCIAL; PREFRONTAL CORTEX; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SOCIAL PERCEPTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84958292189     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.368     Document Type: Article

References (49)

1. Ball TM, Stein MB, Paulus MP (2014a). Toward the application of functional neuroimaging to individualized treatment for anxiety and depression. Depress Anxiety 31: 920-933.
2. Ball TM, Stein MB, Ramsawh HJ, Campbell-Sills L, Paulus MP (2014b). Single-subject anxiety treatment outcome prediction using functional neuroimaging. Neuropsychopharmacology 39: 1254-1261.
3. Barbey AK, Koenigs M, Grafman J (2013). Dorsolateral prefrontal contributions to human working memory. Cortex 49: 1195-1205.
4. Brett M, Anton J-L, Valabregue R, Poline J-B (2002). Region of interest analysis using an SPM toolbox. Presented at the 8th International Conference on Funcational Mapping of the Human Brain; 2-6 June 2002; Sendai, Japan. Available on CD-ROM in NeuroImage, Vol 16, No 2.
5. Buhle JT, Silvers JA, Wager TD, Lopez R, Onyemekwu C, Kober H et al (2014). Cognitive reappraisal of emotion: a meta-analysis of human neuroimaging studies. Cereb Cortex 24: 2981-2990.
6. Caporino NE, Brodman DM, Kendall PC, Albano AM, Sherrill J, Piacentini J et al (2013). Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. J Am Acad Child Adolesc Psychiatry 52: 57-67.
7. Compton SN, Walkup JT, Albano AM, Piacentini JC, Birmaher B, Sherrill JT et al (2010). Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods. Child Adolesc Psychiatry Ment Health 4: 1.
8. Copeland WE, Angold A, Shanahan L, Costello EJ (2014). Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study. J Am Acad Child Adolesc Psychiatry 53: 21-33.
9. Costello EJ, Egger HK, Angold A (2005). The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. Child Adolesc Psychiatr Clin N Am 14: 631-648.
10. Cox RW (1996). AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29: 162-173.
11. Doehrmann O, Ghosh SS, Polli FE, Reynolds GO, Horn F, Keshavan A et al (2013). Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. JAMA Psychiatry 70: 87-97.
12. Frank DW, Dewitt M, Hudgens-Haney M, Schaeffer DJ, Ball BH, Schwarz NF et al (2014). Emotion regulation: quantitative metaanalysis of functional activation and deactivation. Neurosci Biobehav Rev 45: 202-211.
13. Fu CHY, Steiner H, Costafreda SG (2013). Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis 52: 75-83.
14. Gabrieli JDE, Ghosh SS, Whitfield-gabrieli S (2015). Prediction as a humanitarian and pragmatic contribution from human cognitive neuroscience. Neuron 85: 11-26.
15. Goldin PR, McRae K, Ramel W, Gross JJ (2008). The neural bases of emotion regulation: reappraisal and suppression of negative emotion. Biol Psychiatry 63: 577-586.
16. Grubbs FE (1969). Procedures for detecting outlying observations in samples. Technometrics 11: 1-21.
17. Gyurak A, Gross JJ, Etkin A (2011). Explicit and implicit emotion regulation: a dual-process framework. Cogn Emot 25: 400-412.
18. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR (2002). The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 17: 317-323.
19. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36: 980-988.
20. Kendall PC, Choudhury S, Hudson J, Webb A (2002). The C.A.T. Project Workbook. Worbook Publishing: Ardmore, PA, USA.
21. Kendall PC, Hedtke K (2006). Coping Cat Workbook, 2nd edn. Worbook Publishing: Ardmore, PA, USA.
22. Killgore WDS, Yurgelun-Todd DA (2005). Social anxiety predicts amygdala activation in adolescents viewing fearful faces. Neuroreport 16: 1671-1675.
23. Klumpp H, Fitzgerald DA, Phan KL (2013). Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry 45: 83-91.
24. Kober H, Barrett LF, Joseph J, Bliss-Moreau E, Lindquist K, Wager TD (2008). Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies. Neuroimage 42: 998-1031.
25. Kohn N, Eickhoff SB, Scheller M, Laird AR, Fox PT, Habel U (2014). Neural network of cognitive emotion regulation-an ALE meta-analysis and MACM analysis. Neuroimage 87: 345-355.
26. Kujawa A, MacNamara A, Fitzgerald KD, Monk CS, Phan KL (2015). Enhanced neural reactivity to threatening faces in anxious youth: evidence from event-related potentials. J Abnorm Child Psychol 43: 1493-1501.
27. Maslowsky J, Mogg K, Bradley BP, McClure-Tone E, Ernst M, Pine DS et al (2010). A preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder. J Child Adolesc Psychopharmacol 20: 105-111.
28. McClure EB, Adler A, Monk CS, Cameron J, Smith S, Nelson EE et al (2007a). fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) 191: 97-105.
29. McClure EB, Monk CS, Nelson EE, Parrish JM, Adler A, Blair RJR et al (2007b). Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder. Arch Gen Psychiatry 64: 97-106.
30. Merikangas KR, He J-P, Burstein M, Swanson SA, Avenevoli S, Cui L et al (2010). Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49: 980-989.
31. Mohatt J, Bennett SM, Walkup JT (2014). Treatment of separation, generalized, and social anxiety disorders in youths. Am J Psychiatry 171: 741-748.
32. Monk CS (2008). The development of emotion-related neural circuitry in health and psychopathology. Dev Psychopathol 20: 1231-1250.
33. Monk CS, Nelson EE, McClure EB, Mogg K, Bradley BP, Leibenluft E et al (2006). Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry 163: 1091-1097.
34. Nitschke JB, Sarinopoulos I, Oathes DJ, Johnstone T, Whalen PJ, Davidson RJ et al (2009). Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of reatment response. Am J Psychiatry 166: 302-310.
35. Ochsner KN, Gross JJ (2005). The cognitive control of emotion. Trends Cogn Sci 9: 242-249.
36. Phan KL, Coccaro EF, Angstadt M, Kreger KJ, Mayberg HS, Liberzon I et al (2013). Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry 73: 329-336.
37. Phillips ML, Drevets WC, Rauch SL, Lane R (2003). Neurobiology of emotion perception. I: The neural basis of normal emotion perception. Biol Psychiatry 54: 504-514.
38. Plichta MM, Schwarz AJ, Grimm O, Morgen K, Mier D, Haddad L et al (2012). Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery. Neuroimage 60: 1746-1758.
39. Research Units of Pediatric Psychopharmacology Anxiety Study Group (2002). The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 41: 1061-1069.
40. Tanji J, Hoshi E (2008). Role of the lateral prefrontal cortex in executive behavioral control. Physiol Rev 88: 37-57.
41. Thomas KM, Drevets WC, Dahl RE, Ryan ND, Birmaher B, Eccard CH et al (2001). Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 58: 1057-1063.
42. van den Bulk B, Koolschijn PCMP, Meens PHF, van Lang NDJ, van der Wee NJA, Rombouts SARB et al (2013). How stable is activation in the amygdala and prefrontal cortex in adolescence? A study of emotional face processing across three measurements. Dev Cogn Neurosci 4: 65-76.
43. Verduin TL, Kendall PC (2003). Differential occurence of comorbidity within childhood anxiety disorders. J Clin Child Adolesc Psychol 32: 290-295.
44. Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT et al (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 359: 2753-2766.
45. Walter B, Blecker C, Kirsch P, Sammer G, Schienle A, Stark R et al (2003). MARINA: an easy to use tool for the creation of MAsks for Region of INterest Analyses. Presented at the 9th International Conference on Functional Mapping of the Human Brain; 19-22 June 2003; New York, NY, USA. Available on CD-Rom in NeuroImage, Vol. 19, No. 2.
46. Weems CF, Silverman WK (2013). Anxiety disorders. In: Beauchaine T, Hinshaw S (eds). Child and Adolescent Psychopathology. John Wiley: Hoboken, NJ, USA, pp 513-541.
47. Whalen PJ, Johnstone T, Somerville LH, Nitschke JB, Polis S, Alexander AL et al (2008). A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry 63: 858-863.
48. Whitfield-Gabrieli S, Ghosh SS, Nieto-Castanon A, Saygin Z, Doehrmann O, Chai XJ et al (2015). Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry (e-pub ahead of print).
49. Woodward LJ, Fergusson DM (2001). Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 40: 1086-1093.